Suspected Bacterial Endophthalmitis Following Sustained-release Dexamethasone Intravitreal Implant: A Case Report
Korean Journal of Ophthalmology
;
: 275-277, 2014.
Article
in English
| WPRIM
| ID: wpr-51375
ABSTRACT
A 58-year-old man admitted to our opthalmology department with the complaint of branch retinal vein occlusion. He was treated with intravitreal Ozurdex in the right eye. Two days after the injection, the patient presented with ocular pain and the visual acuity was hand movement. A diagnosis of endophthalmitis was made. We performed emergent pars plana vitrectomy (PPV) and the implant was removed from the vitreous cavity using a retinal forceps. A combination of vancomycin 1.0 mg and amikacin 0.4 mg was injected intravitreally. However, because of the blurring in the vitreus one week after the procedure, phacoemulsification and a repeat PPV was performed. Five days after the last procedure the signs and symptoms of endophthalmitis were resolved. Our case demonstrated that endophthalmitis could develop after intravitreal implantation of Ozurdex. Surgical removal of the implant and immediate vitrectomy seems to be a useful treatment option in these cases.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Vitrectomy
/
Retinal Vein Occlusion
/
Dexamethasone
/
Eye Infections, Bacterial
/
Endophthalmitis
/
Device Removal
/
Diagnosis, Differential
/
Drug Implants
/
Intravitreal Injections
/
Glucocorticoids
Type of study:
Diagnostic study
Limits:
Humans
/
Male
Language:
English
Journal:
Korean Journal of Ophthalmology
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS